Holen Sie sich die Stockscreener-App
36.99
5.99%
2.09
Handel nachbörslich:
36.44
-0.55
-1.49%
Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten
NewAmsterdam Pharma (NAMS) Alzheimer’s Data Push Puts Fair Value Back In Focus - Sahm
NAMSNewAmsterdam Pharma Company NV Latest SEC Filings - Finviz
(NAMSW) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
NewAmsterdam Pharma awards stock incentives to four new hires - Stock Titan
NewAmsterdam Pharma puts obicetrapib in Alzheimer’s spotlight at AAIC 2026 - Stock Titan
NewAmsterdam Pharma Company N.V. - TradingView
Price to sales forward of NewAmsterdam Pharma Company N.V. – BOATS:NAMSW - TradingView
Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView
Enterprise value to EBIT forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView
Price to book forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView
Understanding the Setup: (NAMS) and Scalable Risk - Stock Traders Daily
Price to book forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView
Price to book forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView
NewAmsterdam Pharma Company N.V. Actuals & Estimates (NASDAQ:NAMS) - TradingView
NAMS Forecast — Price Target — Prediction for 2027 - TradingView
NewAmsterdam Pharma Company N.V. Actuals & Estimates (MUN:KH6) - TradingView
Enterprise value to EBITDA forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView
Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView
NewAmsterdam Pharma Company N.V. Actuals & Estimates (LSX:A3DUAC) - TradingView
Enterprise value to EBIT forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView
NewAmsterdam Pharma (NAMS) Slides 2.76% as Stock Tests Key Support LevelsRounding Bottom - dars.gov.et
Price to earnings forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView
NewAmsterdam Pharma (NAMS) CAO exercises options and sells 40,000 shares - Stock Titan
Price to earnings forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView
NewAmsterdam Pharma Company NV (NAMS) Institutional Confidence - TradingKey
Breakeven On The Horizon For NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - Moomoo
NewAmsterdam Pharma Company NV (NAMS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NewAmsterdam Pharma Company (NAMS) Proxy filing Summary - Quartr
NAMS News | NEWAMSTERDAM PHARMA CO NV (NASDAQ:NAMS) - ChartMill
NewAmsterdam Pharma Company NV (NAMSW) Institutional Confidence - TradingKey
NewAmsterdam Pharma Company NV (NAMSW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NewAmsterdam Pharma Company NV (NAMSW) Valuation: PE, PB & Fair Value Analysis - TradingKey
NewAmsterdam Pharma Company NV (NAMSW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NewAmsterdam Pharma Company NV (NAMSW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NewAmsterdam Pharma Company NV (NAMS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NewAmsterdam Pharma Company NV (NAMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NewAmsterdam Pharma Company NV (NAMS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NewAmsterdam Pharma Company NV (NAMSW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NewAmsterdam Pharma Company NV - TradingKey
NewAmsterdam Pharma Company NV (NAMSW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NewAmsterdam Pharma Company NV (NAMS) Valuation: PE, PB & Fair Value Analysis - TradingKey
NewAmsterdam Pharma Company NV (NAMS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
The Technical Signals Behind (NAMS) That Institutions Follow - Stock Traders Daily
NewAmsterdam Pharma (NAMS) Slides 1.26% Amidst Cautious Trading, Support at $28.7 HoldsVol Target Rebalance - newsline.com
NAMSW SEC FilingsNewAmsterdam Pha 10-K, 10-Q, 8-K Forms - Stock Titan
NewAmsterdam Pharma Warrants (NAMSW) Plunge 11.78% as Sellers Dominate, Testing Key SupportVolume Weighted Price - newsline.com
NewAmsterdam Pharma Rises 3.17% as Shares Approach Resistance at $31.77Bollinger Band - newsline.com
A Look At NewAmsterdam Pharma (NAMS) Valuation After Recent Share Price Weakness - Yahoo Finance
(NAMSW) Risk Channels and Responsive Allocation - Stock Traders Daily
EBIT of NewAmsterdam Pharma Company N.V. – BX:NAMS - TradingView
NewAmsterdam Pharma Company (NAMS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 - Insider Monkey
All eyes on NewAmsterdam Pharma earnings as pipeline advances - Investing.com
Precision Trading with Newamsterdam Pharma Company N.v. (NAMS) Risk Zones - Stock Traders Daily
Capital World Investors holds 10.4% of NewAmsterdam Pharma (NAMS) - Stock Titan
5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller - Insider Monkey
NewAmsterdam Shareholders Approve ESPP and Governance Proposals - TipRanks
NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions - The Manila Times
Oral cholesterol drug obicetrapib in multiple 2026 lipid meeting studies - Stock Titan
NewAmsterdam Pharma (NASDAQ: NAMS) shareholders back 2026 ESPP and extend share issuance powers - Stock Titan
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):